On the 23rd, it was learned from a press conference held by the State Administration of Traditional Chinese Medicine in Guangzhou that since Guangdong was approved to build a national comprehensive reform demonstration zone for traditional Chinese medicine at the end of 2021, based on the resource endowment and development foundation of Guangdong, Hong Kong, and Macao, it has anchored the goal of building a highland for traditional Chinese medicine in the Guangdong Hong Kong Macao Greater Bay Area, and achieved results in promoting the connection of rules, systems, and integrated development. According to Xu Qingfeng, Director of the Guangdong Provincial Bureau of Traditional Chinese Medicine, Guangdong supports Hong Kong and Macao traditional Chinese medicine practitioners to practice in the mainland of the Greater Bay Area. Currently, 204 Hong Kong and Macao traditional Chinese medicine practitioners are practicing and starting businesses in medical institutions within Guangdong Province; Select traditional Chinese medicine experts to support the construction of traditional Chinese medicine hospitals in Hong Kong; Implement the "Greater Bay Area Chinese Medicine Visiting Scholar Program" to dispatch Chinese medicine experts to Hong Kong and Macao, jointly explore new models of integrated traditional Chinese and Western medicine and new paths for cultivating high-level Chinese medicine talents. Wang Ling, Deputy Director of the Guangdong Provincial Drug Administration, said that the Guangdong Provincial Drug Administration actively promotes the innovative development of drug and medical device supervision in the Guangdong Hong Kong Macao Greater Bay Area, and relevant key tasks have been implemented and effective. Among them, Guangdong promoted the docking of Guangdong, Hong Kong and Macao traditional Chinese medicine regulatory mechanisms, helped high-quality traditional traditional Chinese patent medicines and simple preparations from Hong Kong and Macao to be registered and listed in the mainland, and comprehensively improved Guangdong's ability to review and approve the registration of traditional Chinese medicine. At present, 10 traditional Chinese patent medicines and simple preparations for external use in Hong Kong and Macao have been approved to be registered and listed in the mainland. In supporting the cross-border production of drugs from Hong Kong and Macao in the Greater Bay Area, Guangdong promotes the integrated development of industries in the Greater Bay Area. By pioneering the regulatory model of "Hong Kong and Macao holding+mainland production in the Greater Bay Area", we will leverage the advantages and characteristics of the traditional Chinese medicine industries in Guangdong, Hong Kong and Macao, and promote the formation of a complementary and interactive industrial chain. At present, two Hong Kong drugs, including musk activating oil, have successfully achieved cross-border production and marketing. In addition, Guangdong has also promoted the successful cross-border use of traditional Chinese medicine preparations by medical institutions in the Greater Bay Area to Macau; Support the construction of a series of platforms such as the Guangdong Macao Medical Institution Traditional Chinese Medicine Formulation Center and the Guangdong Hong Kong Macao Traditional Chinese Medicine Policy and Technology Research Center in the Hengqin Guangdong Macao Cooperation Traditional Chinese Medicine Technology Industrial Park, to enhance the comprehensive strength and competitiveness of Hengqin in developing the traditional Chinese medicine industry. (Lai Xin She)